Medicare AdvantagePrior AuthLow impact
Qualaquin® (quinine sulfate) (Revised)
Humana·Infectious Disease, Internal Medicine, Family Medicine·Medicare Advantage
Effective date
Jan 1, 2025
We identified it
Jun 24, 2026
Summary
Humana Medicare Advantage now requires prior authorization for Qualaquin (quinine sulfate) effective January 1, 2025. Coverage is strictly limited to uncomplicated chloroquine-resistant Plasmodium falciparum malaria with specific medical exclusions including QT prolongation, myasthenia gravis, and optic neuritis.
Action Required
By January 1, 2025: Billing team must update prior authorization requirements for Qualaquin (quinine sulfate) prescriptions in Medicare Advantage plans. Verify patients meet criteria for uncomplicated chloroquine-resistant Plasmodium falciparum malaria and do not have contraindications (QT prolongation, myasthenia gravis, optic neuritis). Claims without prior authorization will be denied.